XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.21.2

Stockholders’ Deficit (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Equity [Abstract] |
Schedule of Fair Value of The Warrants | Fair value of the warrants was determined using a Black-Scholes option pricing model with the following inputs: Schedule of Fair Value of The Warrants
Expected term (years) |  |  | 3 years |
Expected volatility |  |  | 118 | %
Expected dividends |  |  | 0 | %
Risk free interest rate |  |  | 0.53 | %
Schedule of Stock Option Transactions | Stock option transactions under the Company’s Plan for the nine months ended September 30, 2021 and the year ended December 31, 2020 are summarized as follows: Schedule of Stock Option Transactions
|  |  |  |  |  |  |  | Weighted |  |  |  |  |  | Weighted |
|  |  |  |  |  |  |  | Average |  |  |  |  |  | Average |
|  |  |  |  | Weighted |  |  | Remaining |  |  | Aggregate |  |  | Grant |
|  | Number of |  |  | Average |  |  | Contractual |  |  | Intrinsic |  |  | Date |
Stock Options |  | Options |  |  | Exercise Price |  |  | Term (Years) |  |  | Value |  |  | Fair Value |
Outstanding - December 31, 2019 |  |  | - |  |  | $ | - |  |  |  | 0.00 |  |  | $ | - |  |  | $ | - |
Exercisable - December 31, 2019 |  |  | - |  |  | $ | - |  |  |  | 0.00 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2020 |  |  | - |  |  | $ | - |  |  |  | 0.00 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2020 |  |  | - |  |  | $ | - |  |  |  | 0 |  |  | $ | - |  |  | $ | - |
Granted |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 7.00 |  |  | $ | - |  |  | $ | 8.75 |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |  |  | $ | - |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  | $ | - |  |  |  |  |  |  | $ | - |  |  |  |  |
Outstanding - December 31, 2020 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 6.16 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2020 |  |  | - |  |  | $ | - |  |  |  | 0.00 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2020 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 6.16 |  |  | $ | - |  |  | $ | - |
Outstanding - December 31, 2020 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 6.16 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - December 31, 2020 |  |  | - |  |  | $ | - |  |  |  | 0.00 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - December 31, 2020 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 6.16 |  |  | $ | - |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  | $ | - |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled/Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding - September 30, 2021 |  |  | 17,004 |  |  | $ | 16.00 |  |  |  | 5.42 |  |  | $ | - |  |  | $ | - |
Vested and Exercisable - September 30, 2021 |  |  | 3,401 |  |  | $ | 16.00 |  |  |  | 5.42 |  |  | $ | - |  |  | $ | - |
Unvested and non-exercisable - September 30, 2021 |  |  | 13,603 |  |  | $ | 16.00 |  |  |  | 5.42 |  |  | $ | - |  |  | $ | - |
Schedule of Stock-based Compensation | Compensation expense recorded for stock-based compensation is as follows for the nine months ended September 30, 2021 and 2020, respectively: Schedule of Stock-based Compensation
Nine Months Ended |
September 30, 2021 |  |  | September 30, 2020 |
$ | 27,880 |  |  | $ | 21,685 |
Schedule of Unvested Options Not Yet Recognized | As of September 30, 2021, compensation cost related to the unvested options not yet recognized was as follows: Schedule of Unvested Options Not Yet Recognized
Compensation expense |  | $ | 89,837 |
Weighted average period in which compensation will vest (years) |  |  | 2.42 |
Schedule of Warrants Activity | Warrant activity for the Nine Months Ended September 30, 2021 and the Year Ended December 31, 2020 are summarized as follows: Schedule of Warrants Activity
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  |  |  |  | Average |  |  |  |
|  |  |  |  | Weighted |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Average |  |  | Contractual |  |  | Intrinsic |
Warrants |  | Warrants |  |  | Exercise Price |  |  | Term (Years) |  |  | Value |
Outstanding and exercisable - December 31, 2019 |  |  | 136,993 |  |  | $ | 35.50 |  |  |  | 1.98 |  |  | $ | - |
Exercisable |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Granted |  |  | 62,325 |  |  | $ | 26.50 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  | (5,000 | ) |  | $ | 40.00 |  |  |  | - |  |  |  | - |
Outstanding - December 31, 2020 |  |  | 194,317 |  |  | $ | 32.50 |  |  |  | 1.52 |  |  | $ | - |
Exercisable - December 31, 2020 |  |  | 194,317 |  |  | $ | 32.50 |  |  |  | 1.52 |  |  | $ | - |
Outstanding - December 31, 2020 |  |  | 194,317 |  |  | $ | 32.50 |  |  |  | 1.52 |  |  | $ | - |
Exercisable - December 31, 2020 |  |  | 194,317 |  |  | $ | 32.50 |  |  |  | 1.52 |  |  | $ | - |
Granted |  |  | 326,075 |  |  | $ | 8.13 |  |  |  | - |  |  |  | - |
Exercised |  |  | (2,133 | ) |  |  | 12.50 |  |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  | (44,650 | ) |  | $ | 23.49 |  |  |  | - |  |  |  | - |
Outstanding - September 30, 2021 |  |  | 473,609 |  |  | $ | 16.68 |  |  |  | 3.21 |  |  | $ | - |
Exercisable - September 30, 2021 |  |  | 473,609 |  |  | $ | 16.68 |  |  |  | 3.21 |  |  | $ | - |

X
- Definition Schedule Of Fair Value Of The Warrants Table Text Block + References No definition available. + Details
Name: | SURG_ScheduleOfFairValueOfTheWarrantsTableTextBlock
Namespace Prefix: | SURG_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration